I saw this on the AMGN board:Immunomedics . . . was forced to shut down clinical trials of an experimental cancer drug after a patient died, according to an analyst who spoke with the company.http://www.thestreet.com/stocks/biotech/1080785.html
Over on the Yahoo board, a respected poster called the Garden State Cancer Center. No one there at GSCC has died.No one in any of the IMMU sponsored trials has died.I don't know who started the rumor about a death, but the "problem" is an administrative one at Garden State.Garden State is affiliated with IMMU's CEO, but is not owned by IMMU
I saw that too, who's trying to sabotage them?Still no news on a buyout, I guess that's hype too.Sounds like the company is turning around. Keep an eye out.
I don't think a buyout is in the cards.I got an email from IR... the partnership discussions seem to still be underway
IMMU is st to take off big time by mid March. With great patent products this stock has been watched by many rolling stock watchers. It is set to take of on the upside. Climb aboard if you like making money. I have.
<<IMMU is st to take off big time by mid March>>What makes you think that?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |